EGRX FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Eagle Pharmaceuticals (EGRX) Investors with Substantial Losses to Contact Firm Before Feb. 9th Deadline in Securities Fraud Class Action
February 08, 2024 09:52 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors who suffered substantial losses to submit your losses now. Class Period:...
Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman
February 05, 2024 09:55 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors who suffered substantial losses to submit your losses now. Class Period:...
Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman
February 01, 2024 16:05 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors who suffered substantial losses to submit your losses now. Class...
EGRX 11-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Eagle Pharmaceuticals (EGRX) Investors with Substantial Losses to Contact Firm Before Feb. 9th Deadline in Securities Fraud Class Action
January 29, 2024 13:01 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors who suffered substantial losses to submit your losses now. Class Period:...
Eagle Pharmaceuticals’ (EGRX) Line of Credit Reduced Amid Pending Restatement and Securities Fraud Class Action - Hagens Berman
January 26, 2024 09:12 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors who suffered substantial losses to submit your losses now. Class Period:...
Eagle Pharmaceuticals’ (EGRX) Line of Credit Reduced Amid Pending Restatement and Securities Fraud Class Action - Hagens Berman
January 22, 2024 16:03 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors who suffered substantial losses to submit your losses now. Class...
Eagle Pharmaceuticals’ (EGRX) Line of Credit Reduced Amid Pending Restatement and Securities Fraud Class Action - Hagens Berman
January 19, 2024 12:13 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors who suffered substantial losses to submit your losses now. Class Period:...
EGRX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Eagle Pharmaceuticals (EGRX) Investors with Substantial Losses to Contact Firm, Securities Fraud Lawsuit Filed After Company Admits Accounting Problems
January 15, 2024 15:45 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors who suffered substantial losses to submit your losses now. Class...
Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman
January 12, 2024 10:12 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors who suffered substantial losses to submit your losses now. Class Period:...
Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman
January 08, 2024 17:43 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors who suffered substantial losses to submit your losses now. Class Period:...